NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease
暂无分享,去创建一个
R. Mashal | K. Ataga | E. Vichinsky | R. Schaub | D. Nathan | E. Majerus | Joshua J Field | Elaine M. Majerus
[1] P. Frenette,et al. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. , 2016, Blood.
[2] Joshua J Field. Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease? , 2015, Hematology. American Society of Hematology. Education Program.
[3] R. Mashal,et al. Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo , 2015, PloS one.
[4] S. Jameson,et al. Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response. , 2015, Immunity.
[5] V. Cerundolo,et al. The Regulatory Role of Invariant NKT Cells in Tumor Immunity , 2015, Cancer Immunology Research.
[6] E. Engleman,et al. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production , 2015, European journal of immunology.
[7] R. Mashal,et al. Antibody Mediated Depletion of iNKT Cells Protects Against Hypoxia-Induced Pulmonary Injury in a Murine Model of Sickle Cell Disease , 2014 .
[8] R. Mashal,et al. A Humanized Monoclonal Antibody Specific for Invariant Natural Killer T (iNKT) Cells for In Vivo Depletion , 2013, PloS one.
[9] M. Kronenberg,et al. The role of invariant natural killer T cells in microbial immunity , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[10] D. Neuberg,et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. , 2013, Blood.
[11] G. Besra,et al. Invariant natural killer T cells recognize lipid self-antigen induced by microbial danger signals , 2011, Nature Immunology.
[12] A. Luster,et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1–ICAM-1 interactions , 2011, The Journal of experimental medicine.
[13] Shin-Seok Lee,et al. Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. , 2011, Rheumatology.
[14] J. Linden,et al. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. , 2010, Blood.
[15] M. Zayat,et al. A DIRECT ROLE FOR SECRETORY PHOSPHOLIPASE A2 AND LYSOPHOSPHATIDYLCHOLINE IN THE MEDIATION OF LPS-INDUCED GASTRIC INJURY , 2010, Shock.
[16] K. Ataga,et al. The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up , 2010, American journal of hematology.
[17] Vrajesh V. Parekh,et al. Invariant natural killer T cells: bridging innate and adaptive immunity , 2010, Cell and Tissue Research.
[18] E. Adams,et al. Recognition of Lyso-Phospholipids by Human Natural Killer T Lymphocytes , 2009, PLoS biology.
[19] R. Strieter,et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. , 2009, Blood.
[20] A. Balato,et al. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. , 2009, The Journal of investigative dermatology.
[21] Wilfried Bardet,et al. Determination of Cellular Lipids Bound to Human CD1d Molecules , 2009, PloS one.
[22] Anneliese O. Speak,et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. , 2008, The Journal of clinical investigation.
[23] Anneliese O. Speak,et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation , 2007, Proceedings of the National Academy of Sciences.
[24] M. Kronenberg,et al. The unique role of natural killer T cells in the response to microorganisms , 2007, Nature Reviews Microbiology.
[25] G. Sireci,et al. Immunoregulatory role of Jα281 T cells in aged mice developing lupus‐like nephritis , 2007, European journal of immunology.
[26] Courtney M. Lappas,et al. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation , 2006, The Journal of experimental medicine.
[27] G. Victorino,et al. Hydrolysis of Phosphatidylserine-exposing Red Blood Cells by Secretory Phospholipase A2 Generates Lysophosphatidic Acid and Results in Vascular Dysfunction* , 2006, Journal of Biological Chemistry.
[28] D. Purdie,et al. Modulation of human Vα24+Vβ11+ NKT cells by age, malignancy and conventional anticancer therapies , 2004, British Journal of Cancer.
[29] M. Taniguchi,et al. Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection , 2003, European journal of immunology.
[30] Timothy K Starr,et al. Positive and negative selection of T cells. , 2003, Annual review of immunology.
[31] J. Orange,et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. , 2003, The Journal of infectious diseases.
[32] S. Behar,et al. Role of CD1d-Restricted NKT Cells in Microbial Immunity , 2003, Infection and Immunity.
[33] M. Dhodapkar,et al. A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma , 2003, The Journal of experimental medicine.
[34] M. Brenner,et al. Understanding the function of CD1-restricted T cells , 2003, Nature Immunology.
[35] J. Orange. Human natural killer cell deficiencies and susceptibility to infection. , 2002, Microbes and infection.
[36] J. Glickman,et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung , 2002, Nature Medicine.
[37] Lubin,et al. Phospholipase A 2 Levels in Acute Chest Syndrome of Sickle Cell Disease , 2002 .
[38] M. Kronenberg,et al. NKT cells derive from double-positive thymocytes that are positively selected by CD1d , 2001, Nature Immunology.
[39] Seung-Hwan Lee,et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily , 2001, Nature Genetics.
[40] M. Taniguchi,et al. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. , 2000, International immunology.
[41] M L Terrin,et al. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. , 1997, Blood.
[42] C. Schalkwijk,et al. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. , 1996, Blood.
[43] M L Terrin,et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.
[44] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.